FDA Investigator Samuel Rudnitsky
Samuel Rudnitsky has conducted inspections on 93 sites in 14 countries as of 21 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
93
Last Inspection Date:
21 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Japan,
Italy,
Spain,
Philippines,
Morocco,
Chile,
Canada,
Sri Lanka,
Mexico,
China,
Indonesia,
Netherlands,
Hong Kong,
United States of America
FDA Investigators that have inspected at least one site in common with Samuel Rudnitsky:
Aaron J Fox,
Alexandra B Pitkin,
Brian L Szcyubialka,
Brian P Putz,
Bruce R Burrell,
Bush,
Cathleen A Carr Sharpe,
Clara E Santiago,
Cody J Alley,
Darrin E Davis,
David Y Hernandez,
Deborah A Greco,
Dejon N Harris,
Devon M Shoop,
Durell L Giles,
Francisco,
G Steven Condrey,
Gale L Glinecki,
Garciam,
Gary S Condrey,
Gene D Arcy,
Gordon Chu,
Grant D Jones,
Hagstrom,
Herminio C Francisco,
Jake T Lane,
James A Barreto,
James P Stallings,
Jane C Chen,
Jeff M Uriarte,
Jessica B Zachman,
Jinnie Kokiatkulkij,
Judy C Nepsa,
Kelvin X Sanders,
Kevin T Gerrity,
Kimberly M Lichter,
Lakecha N Lewis,
Liliya V Bubiy,
Lilly O Barton,
Marcus F Yambot,
Matthew B Thomaston,
Michael E Campbell,
Mohammed H Adam,
Natalie J Ayoub,
Naveen B Walker,
Nianna C Burns,
Nirana Capula,
Nympha V Florendo,
Osama M Hamoud,
Phillip L Toy,
Rashonda N Rucker,
Rebecca L Keller,
Richard G Fochesato,
Romero,
Sandra I Gaul,
Sara Jdent Acosta,
Sean P Desbrow,
Sparky L Bartee,
Tammy Vasquez Hancock,
Tara M Aikens,
Tara M Mussatto,
Thomas J Hudson,
Thomas Martinez,
Thomas Siebertz,
Trushani T Desai,
Valerie C Reed
Samuel Rudnitsky's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2013 | FDA 483 | Malteurop Canada - Form 483, 2013-03-28 |
October, 2002 | FDA 483 | Uni-President USA Inc - Form 483, 2002-10-18 |
March, 2013 | FDA 483 | Delmar Commodities - Form 483, 2013-03-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more